# Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects

> **NCT00708318** · PHASE1 · COMPLETED · sponsor: **YM BioSciences** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** i.v. fentanyl and AeroLEF

## Key facts

- **NCT ID:** NCT00708318
- **Lead sponsor:** YM BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2001-11
- **Final completion:** 2002-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2008-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708318, "Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00708318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*